A Long-term, Prospective, Observational Cohort Study Of The Safety And Effectiveness Of Etanercept In The Treatment Of Paediatric Psoriasis Patients In A Naturalistic Setting: A Post-authorization Safety Study (Pass)

Trial Profile

A Long-term, Prospective, Observational Cohort Study Of The Safety And Effectiveness Of Etanercept In The Treatment Of Paediatric Psoriasis Patients In A Naturalistic Setting: A Post-authorization Safety Study (Pass)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions
  • Acronyms PURPOSE
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Sep 2016 Planned number of patients changed from 70 to 80.
    • 28 Oct 2015 Planned number of patients changed from 60 to 70 as reported by ClinicalTrials.gov.
    • 11 Jun 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top